Glembatumumab Vedotin
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Glembatumumab Vedotin, covering 2018-05-21 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer [EARLY_Phase 1]